Vascular Spread of Carcinoma of the Bronchus * by H
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Table of Contents 1
GENERAL THORACIC SURGERY DATABASE v.2.3 TRAINING MANUAL January 2018 Table of Contents 1. Demographics ................................................................................................................................................................. 2 2. Follow Up ........................................................................................................................................................................ 9 3. Admission ..................................................................................................................................................................... 10 4. Pre-Operative Evaluation ............................................................................................................................................. 14 5. Diagnosis (Category of Disease) ................................................................................................................................... 49 6. Procedure ..................................................................................................................................................................... 72 7. Post-Operative Events ................................................................................................................................................ 114 8. Discharge .................................................................................................................................................................... 141 9. Quality Measures ...................................................................................................................................................... -
Collaborative Stage Manual Part II
SEER Program Coding and Staging Manual 2004, Revision 1 Collaborative Staging Codes Nasal Cavity C30.0 C30.0 Nasal cavity (excludes nose, NOS C76.0) Note: Laterality must be coded for this site, except subsites Nasal cartilage and Nasal septum, for which laterality is coded 0. CS Tumor Size CS Site-Specific Factor 1 - Size of The following tables are available CS Extension Lymph Nodes at the collaborative staging CS TS/Ext-Eval CS Site-Specific Factor 2 - website: CS Lymph Nodes Extracapsular Extension, Lymph Nodes Histology Exclusion Table CS Reg Nodes Eval for Head and Neck AJCC Stage Reg LN Pos CS Site-Specific Factor 3 - Levels I- Lymph Nodes Size Table Reg LN Exam III, Lymph Nodes for Head and Neck CS Mets at DX CS Site-Specific Factor 4 - Levels IV- CS Mets Eval V and Retropharyngeal Lymph Nodes for Head and Neck CS Site-Specific Factor 5 - Levels VI- VII and Facial Lymph Nodes for Head and Neck CS Site-Specific Factor 6 - Parapharyngeal, Parotid, Preauricular, and Sub-Occipital Lymph Nodes, Lymph Nodes for Head and Neck Nasal Cavity CS Tumor Size SEE STANDARD TABLE Nasal Cavity CS Extension Code Description TNM SS77 SS2000 00 In situ; non-invasive Tis IS IS 10 Invasive tumor confined to site of origin T1 L L Meatus (superior, middle, inferior) Nasal chonchae (superior, middle, inferior) Septum Tympanic membrane 30 Localized, NOS T1 L L 40 Extending to adjacent connective tissue within the nasoethomoidal T2 RE RE complex Nasolacrimal duct 60 Adjacent organs/structures including: T3 RE RE Bone of skull Choana Frontal sinus Hard palate -
Structure, Function, and Molecular Control of the Skin Lymphatic System
CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Structure, Function, and Molecular Control of the Skin Lymphatic System Mihaela Skobe and Michael Detmar Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, U.S.A. The mechanisms of angiogenesis have been studied phatic vasculature and the differences between blood extensively over the past years. The focus, however, and lymphatic vessels. Special attention has been has been almost exclusively on blood vessels, whereas given to the methods employed in research of the little effort has been directed toward understanding lymphatic system. Finally, we describe molecular lymphangiogenesis and the role of lymphatic vessels mechanisms involved in the regulation of lymphan- in physiology and pathology. The lymphatic system, giogenesis. Vascular endothelial growth factor and acting in concert with the blood vascular system, is vascular endothelial growth factor-C, expressed by of fundamental importance in maintaining tissue distinct skin cell populations, play an important role homeostasis, and disorders of the lymphatic system in the molecular control of skin angiogenesis and are common, often resulting in chronic, disabling lymphangiogenesis. Key words: lymphatic vessels/lymph- conditions. This overview summarizes the most angiogenesis/skin/VEGF-C. Journal of Investigative important aspects of the structure and function of Dermatology Symposium Proceedings 5:14±19, 2000 the lymphatic system with emphasis on the skin lym- ur understanding of the biology of the lymphatic covered'' (Bartels, 1909). The ancient Greeks observed structures system is well illustrated by the word lymphatic containing colorless ¯uid (Hippocrates spoke of ``white blood'') but itself; the derivation of the latin word lymphaticus their function was not understood and the signi®cance of the signi®es ``distracted and confused'' (Witte et al, ®nding was not recognized. -
Lymphatic Tissue Engineering and Regeneration Laura Alderfer1, Alicia Wei1 and Donny Hanjaya-Putra1,2,3,4,5,6*
Alderfer et al. Journal of Biological Engineering (2018) 12:32 https://doi.org/10.1186/s13036-018-0122-7 REVIEW Open Access Lymphatic Tissue Engineering and Regeneration Laura Alderfer1, Alicia Wei1 and Donny Hanjaya-Putra1,2,3,4,5,6* Abstract The lymphatic system is a major circulatory system within the body, responsible for the transport of interstitial fluid, waste products, immune cells, and proteins. Compared to other physiological systems, the molecular mechanisms and underlying disease pathology largely remain to be understood which has hindered advancements in therapeutic options for lymphatic disorders. Dysfunction of the lymphatic system is associated with a wide range of disease phenotypes and has also been speculated as a route to rescue healthy phenotypes in areas including cardiovascular disease, metabolic syndrome, and neurological conditions. This review will discuss lymphatic system functions and structure, cell sources for regenerating lymphatic vessels, current approaches for engineering lymphatic vessels, and specific therapeutic areas that would benefit from advances in lymphatic tissue engineering and regeneration. Keywords: Lymphangiogenesis, Tissue Engineering, Disease Modeling, Wound Healing, Lymphedema, Stem Cells, Biomaterials, Interstitial Fluid, Regeneration I. Introduction to the Lymphatic System and its role Interstitial fluid (IF) is a plasma filtrate that is generated Function by transcapillary filtration and is governed by Starling The lymphatic system is nearly ubiquitous in the human forces, the net difference between hydrostatic and body, present in all tissues except the epidermis, cartil- osmotic pressures, at the microcirculatory level [9]. In age, eye lens, cornea, retina, and bone marrow [1, 2]. order to maintain fluid homeostasis, lymph formation in The main functions of the lymphatic system include the initial lymphatic vessels must be balanced by the net fluid homeostasis and interstitial fluid drainage, immune flux of plasma being filtered out [4]. -
Human and Nonhuman Primate Meninges Harbor Lymphatic Vessels
SHORT REPORT Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI Martina Absinta1†, Seung-Kwon Ha1†, Govind Nair1, Pascal Sati1, Nicholas J Luciano1, Maryknoll Palisoc2, Antoine Louveau3, Kareem A Zaghloul4, Stefania Pittaluga2, Jonathan Kipnis3, Daniel S Reich1* 1Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, United States; 2Hematopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, United States; 3Center for Brain Immunology and Glia, Department of Neuroscience, School of Medicine, University of Virginia, Charlottesville, United States; 4Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, United States Abstract Here, we report the existence of meningeal lymphatic vessels in human and nonhuman primates (common marmoset monkeys) and the feasibility of noninvasively imaging and mapping them in vivo with high-resolution, clinical MRI. On T2-FLAIR and T1-weighted black-blood imaging, lymphatic vessels enhance with gadobutrol, a gadolinium-based contrast agent with high propensity to extravasate across a permeable capillary endothelial barrier, but not with gadofosveset, a blood-pool contrast agent. The topography of these vessels, running alongside dural venous sinuses, recapitulates the meningeal lymphatic system of rodents. In primates, *For correspondence: meningeal -
New Brain Lymphatic Vessels Drain Old Concepts
EBioMedicine 2 (2015) 776–777 Contents lists available at ScienceDirect EBioMedicine journal homepage: www.ebiomedicine.com In Focus New Brain Lymphatic Vessels Drain Old Concepts Lasse Dissing-Olesen, Soyon Hong, Beth Stevens⁎ Department of Neurology, F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA The brain has traditionally been considered an immune privileged vessels above the dcLN completely abolished drainage of dye to these organ, in part due to the lack of evidence for lymphatic vasculature lymph nodes and additionally, increased the diameter of the meningeal (Galea et al., 2007). Two centuries ago, the existence of lymphatic ves- lymphatic vessels, indicating that these vessels drain to the dcLN. The sels on the surface of the human brain was proposed but it has since Alitalo lab further demonstrated that dye injected into the brain paren- been widely dismissed (Lukic et al., 2003). Therefore, while T cells chyma was absorbed by lymphatic vessels and preferentially drained leave all other organs via the lymphatic system to reach nearby lymph into the ipsilateral dcLN from the base of the brain. Surprisingly, Kipnis' nodes, the prevailing view has been that infiltrated T cells exit the lab excluded the best-known route of drainage into the dcLN, via the brain via venous blood circulation, circumventing the lymph nodes nasal cavity's cribriform plate and the nasal mucosa (Kida et al., 1995), (Ransohoff and Engelhardt, 2012). The recent evidence for the existence as they failed -
Extraperitoneal Laparoscopic Resection for Retroperitoneal Lymphatic Cysts
Wang et al. BMC Urology (2017) 17:101 DOI 10.1186/s12894-017-0288-1 RESEARCHARTICLE Open Access Extraperitoneal laparoscopic resection for retroperitoneal lymphatic cysts: initial experience Yichun Wang1†, Chen Chen1†, Chuanjie Zhang1†, Chao Qin2* and Ninghong Song2* Abstract Background: To assess the safety and efficacy of laparoscopic retroperitoneal resection for retroperitoneal lymphatic cysts. Methods: A retrospective analysis was conducted based on clinical data from eight patients with hydronephrosis caused by retroperitoneal lymphatic cysts. All patients underwent laparoscopic retroperitoneal lymphatic cyst resection and received postoperative follow-up. A follow-up ultrasound was performed postoperatively every 6–12 months to evaluate the recovery of the hydronephrosis. Results: All operations were successful, and their postoperative pathological results revealed lymphatic cyst walls. The operation time ranged from 43 to 88 min (mean: 62 min), with a blood loss of 20 to 130 mL (mean: 76 mL), and the length of hospital stay was 3 to 6 days (mean: 4.5 days). Within the follow-up of 12 to 36 months (mean: 28.5 months), great relief was detected in all eight cases, and no recurrence was found. Moreover, complications such as renal pedicle or renal pelvis injury were not observed. Conclusions: Laparoscopic retroperitoneal lymphatic cyst resection is an effective treatment for retroperitoneal lymphatic cysts and has the advantages of being minimally invasive, producing less intraoperative blood loss and leading to a quick recovery. This treatment thus deserves further studies. Keywords: Hydronephrosis, Lymphatic cyst, Laparoscope Background pain, obstructive uropathy, lower lymphoedema, bowel Lymphatic cysts are a rare lymphatic-vessel-generated obstruction and venous thrombosis [7–10]. -
Lateral Peritumoral Lymphatic Vessel Invasion Can Predict Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma
Modern Pathology (2007) 20, 694–700 & 2007 USCAP, Inc All rights reserved 0893-3952/07 $30.00 www.modernpathology.org Lateral peritumoral lymphatic vessel invasion can predict lymph node metastasis in esophageal squamous cell carcinoma Daisuke Mori1, Fumio Yamasaki1, Masami Shibaki1 and Osamu Tokunaga2 1Division of Pathology, Saga Prefectural Hospital Kouseikan, Saga, Japan and 2Faculty of Medicine, Department of Pathology and Biodefense, Saga University, Saga, Japan Lymph node metastasis is an important prognostic factor in many types of cancer. We investigated the clinical significance of lymphangiogenesis and lymphatic vessel invasion in esophageal squamous cell carcinoma. We evaluated lymphatic vessel density and lymphatic vessel invasion in the intratumoral, peritumoral and normal compartments using D2-40 immunostaining. In addition, the peritumoral compartment was divided into the lateral peritumoral compartment and the non-lateral peritumoral compartment. The lymphatic vessel density was higher in the peritumoral and intratumoral compartments than in the normal compartment. However, the lymphatic vessel density did not correlate with any pathological parameters including lymph node metastasis. Intratumoral and peritumoral lymph vessels were small and collapsed while normal lymphatic vessels and lymphatic vessels with lymphatic vessel invasion were dilated and large. The presence of lymphatic vessel invasion, in the lateral peritumoral compartment but nowhere else, significantly correlated with lymph node metastasis. These results -
Increased Number and Altered Phenotype of Lymphatic Vessels in Peripheral Lung Compartments of Patients with COPD Mori Et Al
Increased number and altered phenotype of lymphatic vessels in peripheral lung compartments of patients with COPD Mori et al. Mori et al. Respiratory Research 2013, 14:65 http://respiratory-research.com/content/14/1/65 Mori et al. Respiratory Research 2013, 14:65 http://respiratory-research.com/content/14/1/65 RESEARCH Open Access Increased number and altered phenotype of lymphatic vessels in peripheral lung compartments of patients with COPD Michiko Mori1, Cecilia K Andersson2, Gerard J Graham3, Claes-Göran Löfdahl2 and Jonas S Erjefält1,2* Abstract Background: De novo lymphatic vessel formation has recently been observed in lungs of patients with moderate chronic obstructive pulmonary disease (COPD). However, the distribution of lymphatic vessel changes among the anatomical compartments of diseased lungs is unknown. Furthermore, information regarding the nature of lymphatic vessel alterations across different stages of COPD is missing. This study performs a detailed morphometric characterization of lymphatic vessels in major peripheral lung compartments of patients with different severities of COPD and investigates the lymphatic expression of molecules involved in immune cell trafficking. Methods: Peripheral lung resection samples obtained from patients with mild (GOLD stage I), moderate-severe (GOLD stage II-III), and very severe (GOLD stage IV) COPD were investigated for podoplanin-immunopositive lymphatic vessels in distinct peripheral lung compartments: bronchioles, pulmonary blood vessels and alveolar walls. Control subjects with normal lung function were divided into never smokers and smokers. Lymphatics were analysed by multiple morphological parameters, as well as for their expression of CCL21 and the chemokine scavenger receptor D6. Results: The number of lymphatics increased by 133% in the alveolar parenchyma in patients with advanced COPD compared with never-smoking controls (p < 0.05). -
Guidelines on the Diagnosis and Treatment of Primary Lung Cancer (2011)
G U I D E L I N E S Chinese guidelines on the diagnosis and treatment of primary lung cancer (2011) Xiu-yi Zhi1*, Yi-long Wu2*, Hong Bu3, Gang Cheng4, Ying Cheng5, Xiang Du6, Bao-hui Han7, Ge-ning Jiang8, Shun- chang Jiao9, De-ruo Liu10, Lun-xu Liu3, You Lu3, Sheng-lin Ma11, Yuan-kai Shi12, Chang-li Wang13, Jie Wang14, Tian- you Wang1, Yue Yang14, Qing-hua Zhou15, Lung Cancer Diagnosis and Treatment Expert Panel of the Chinese Ministry of Health 1Beijing Lung Cancer Center, Capital Medical University, Beijing; 2Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou; 3West China Medical School, West China Hospital, Sichuan University, Chengdu; 4Beijing Hospital, Beijing; 5Cancer Hospital of Jilin Province, Changchun; 6Cancer Hospital of Fudan University, Shanghai; 7Shanghai Chest Hospital, Jiaotong University, Shanghai; 8Shanghai Pulmonary Hospital, Tongji University, Shanghai; 9General Hospital of Chinese People's Liberation Army, Beijing; 10Beijing Sino-Japan Hospital, Beijing; 11Hangzhou Cancer Hospital, Hangzhou; 12Cancer Institute and Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing; 13Tianjin Cancer Hospital, Tianjin Medical University, Tianjin; 14Beijing Cancer Hospital, Peking University, Beijing; 15Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital J Thorac Dis 2012;4:88-101. DOI: 10.3978/j.issn.2072-1439.2010.08.01 Introduction . smoking with a smoking index of greater than 400 cigarettes/ year; a history of high-risk occupational exposure (eg. exposure Primary lung cancer (PLC) is one of the most common to asbestos) and family history of PLC; or at the age of 45 years malignant tumors in China. -
TNM Classification of Malignant Tumours
Table of Contents Cover Title Page Preface References Acknowledgments Organizations Associated with the TNM System Members of UICC Committees Associated with the TNM System Section Editors Introduction References Head and Neck Tumours Lip and Oral Cavity Pharynx References Larynx Nasal Cavity and Paranasal Sinuses Unknown Primary – Cervical Nodes Malignant Melanoma of Upper Aerodigestive Tract Major Salivary Glands Thyroid Gland Digestive System Tumours Oesophagus Stomach Reference Small Intestine Appendix Colon and Rectum Anal Canal and Perianal Skin Liver Intrahepatic Bile Ducts Gallbladder Perihilar Bile Ducts Distal Extrahepatic Bile Duct Ampulla of Vater Pancreas Well Differentiated Neuroendocrine Tumours of the Gastrointestinal Tract Lung, Pleural, and Thymic Tumours Lung References Pleural Mesothelioma Thymic Tumours References Tumours of Bone and Soft Tissues Bone Soft Tissues Gastrointestinal Stromal Tumour (GIST) Skin Tumours Carcinoma of Skin (excluding eyelid, head and neck, perianal, vulva, and penis) Skin Carcinoma of the Head and Neck Carcinoma of Skin of the Eyelid Malignant Melanoma of Skin Merkel Cell Carcinoma of Skin Breast Tumours Reference Gynaecological Tumours Reference Vulva Vagina Cervix Uteri Uterus – Endometrium Reference Uterine Sarcomas References Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma Reference Gestational Trophoblastic Neoplasms Reference Urological Tumours Penis Prostate References Testis Kidney Renal Pelvis and Ureter Urinary Bladder Urethra Adrenal Cortex (ICD O 3 C74.0) Ophthalmic -
Lymphangiogenesis Guidance by Paracrine and Pericellular Factors
Downloaded from genesdev.cshlp.org on October 10, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Lymphangiogenesis guidance by paracrine and pericellular factors Kari Vaahtomeri,1 Sinem Karaman,1 Taija Mäkinen,2 and Kari Alitalo1 1Wihuri Research Institute, Translational Cancer Biology Program, Biomedicum Helsinki, University of Helsinki, FI-00014 Helsinki, Finland; 2Department of Immunology, Genetics, and Pathology, Uppsala University, 75185 Uppsala, Sweden Lymphatic vessels are important for tissue fluid homeo- in the downstream collector vessels (Bazigou and Maki- stasis, lipid absorption, and immune cell trafficking and nen 2013). are involved in the pathogenesis of several human diseas- With the exception of the Schlemm’s canal in the eyes, es. The mechanisms by which the lymphatic vasculature meningeal lymphatic vessels, and the majority of the (lac- network is formed, remodeled, and adapted to physiolog- teal) lymphatic vessels in the intestine, most lymphatic ical and pathological challenges are controlled by an intri- networks are generated during embryonic development cate balance of growth factor and biomechanical cues. (Kim et al. 2007; Aspelund et al. 2014, 2015; Kizhatil These transduce signals for the readjustment of gene ex- et al. 2014; Nurmi et al. 2015). However, they also under- pression and lymphatic endothelial migration, prolifera- go dynamic changes in adults. Lymphatic vessels can tion, and differentiation. In this review, we describe grow in length and caliber (lymphangiogenesis) in various several of these cues and how they are integrated for the pathological conditions, such as inflammation, wound generation of functional lymphatic vessel networks. healing, tumorigenesis, and in association with tissue transplantation. A common feature in many of these con- ditions is tissue edema and inflammation, which increase Some of the most dense lymphatic networks are located the demand for fluid drainage and immune cell traffick- under various epithelia that form the interface between ing.